SCHEMBL12356732

SCHEMBL12356732

CCNc1ccc2c(OC)cccc2n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 4/20 0.61
SLC2A1 P11166 1/20 0.48
GRM5 P41594 2/20 0.48
KCNH2 Q12809 2/20 0.48
MCHR1 Q99705 1/20 0.43
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
PGK1 P00558 2/20 0.42
RAF1 P04049 1/20 0.42
BRAF P15056 1/20 0.42
BCHE P06276 2/20 0.41
ACHE P22303 2/20 0.41
POLB P06746 1/20 0.41
APP P05067 1/20 0.40
NQO2 P16083 1/20 0.40
HTR1A P08908 1/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.40
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21217198 0.83 NCF1 (0.53) NCF1SLC2A1GRM5KCNH2MCHR1
SCHEMBL27060737 0.83 NCF1 (0.65) NCF1SLC2A1GRM5KCNH2MCHR1
SCHEMBL2253396 0.82 CYP1A2 (0.55) SLC2A1LMNASMN1; SMN2HPGDCYP1A2
SCHEMBL12356709 0.79 NCF1 (0.51) NCF1SLC2A1GRM5KCNH2BCHE
SCHEMBL12356730 0.78 NCF1 (0.50) NCF1KCNH2BCHEACHEAPP
SCHEMBL12356706 0.78 NCF1 (0.56) NCF1KCNH2BCHEACHEPOLB
SCHEMBL12356704 0.78 NCF1 (0.50) NCF1GRM5KCNH2BCHEACHE
SCHEMBL13040668 0.77 NCF1 (0.63) NCF1POLBLMNASMN1; SMN2HPGD
SCHEMBL31109926 0.77 NCF1 (0.50) NCF1SLC2A1GRM5KCNH2RAF1
SCHEMBL21195763 0.77 NCF1 (0.50) NCF1SLC2A1GRM5KCNH2RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989628-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2011-08-02 US disclosed
US-20090227628-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227628-A1 2-AMINOQUINOLINES HTR5A, HTR1A, HTR1E NCF1 2971/4885SLC2A1 2139/4885GRM5 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.